It targets oncogenic proteins, such as BCL-6 or the Snail family of transcription factors, for degradation, thereby exhibiting a tumor-suppressive function in various cancer types, such as diffuse large B-cell lymphomas and lung cancer [37,42]. This evidence concerns the gene BCL6 and neoplasm.